Self-medication misuse is high in the Middle East

June 19, 2017

A new review indicates that there is a massive problem of self-medication misuse in the Middle East. The findings, which are published in Pharmacology Research & Perspectives, indicate the need for better patient and physician education, as well as improved policies that restrict sales of prescription medications without a prescription.

Self-medication is not limited to over-the-counter medicines. Patients self-medicate with that may have been prescribed and left over from a previous time. Also, even though it's not authorized, in some countries individuals sometimes buy prescription medicines directly from community pharmacies, especially for the short-term treatment of common diseases.

In the Middle East, prescription medicines can easily be purchased without a prescription, resulting in potential misuse and unnecessary risk. To examine self-medication misuse in the Middle East, Dr. Malak Khalifeh, of the Bordeaux University in France, and her colleagues conducted an extensive review of literature published between 1990 and 2015.

The team identified a total of 72 papers. Medicines involved in misuse included codeine containing products, topical anesthetics, topical corticosteroids, antimalarial drugs, and antibiotics. Self-medication misuse seemed widespread, and pharmacists, friends, and parents were the main sources of medications. One study noted that pharmacies in Iran sold 57% of prescription items without a prescription. Another found that in Syria, 87% of 200 pharmacies visited agreed to sell antibiotics without a prescription. This figure increased to 97% when the investigators who were at first denied antibiotics insisted on having the . In Saudi Arabia, only one attendant pharmacist refused to dispense medications without a prescription. Strategies and interventions to limit misuse were rarely mentioned in studies.

The findings indicate that there is a serious problem of self-medication misuse in the Middle East involving a range of medicines. "There is a relative lack of literature relating to self-medication misuse in the Middle East, and there has been relatively little systematic research on this topic, partly due to the perception that self-mediation misuse is not as problematic as other types of drug abuse," said Dr. Khalifeh. "This review has found a massive problem, and it could be used as a reference for multiple research studies that deal with self-medication misuses in Middle Eastern countries."

Explore further: Effects of teen prescription stimulant misuse linger into adulthood

More information: Malak M. Khalifeh et al, Self-medication misuse in the Middle East: a systematic literature review, Pharmacology Research & Perspectives (2017). DOI: 10.1002/prp2.323

Related Stories

Effects of teen prescription stimulant misuse linger into adulthood

March 3, 2017
Teens should think twice if they believe the negative effects from misusing medication to treat ADHD are short-term. In fact, problems associated with prescription stimulant misuse can last through age 35, according to a ...

Many elderly people are receiving and using prescription medications inappropriately

July 17, 2016
A new study from Belgium indicates that the majority of community-dwelling elderly adults are taking prescription medications inappropriately. The study, which is published in the British Journal of Clinical Pharmacology, ...

Nonmedical use of prescription drugs among young people: A growing global concern

February 2, 2017
Balancing a country's need to make prescription drugs available to those in need while simultaneously curbing nonmedical use is one of our greatest challenges, according to a perspective article just published by Silvia Martins, ...

Improved vigilance of non-prescription medicine needed to reduce abuse, according to new survey

February 2, 2016
A cross-sectional survey has been used to estimate the prevalence of self-reported non-prescription medicine misuse, which has found that almost a fifth of people could have misused medicines in some way over their lifetime. ...

Study finds many patients abusing drugs and alcohol are self-medicating chronic pain

May 9, 2016
With opioid addiction and prescription drug abuse considered one of the biggest public health threats of our time in the U.S., many are asking why so many Americans are struggling with addiction to illegal drugs and prescription ...

Teens world-wide self-medicate with over-the-counter and prescription drugs

September 24, 2014
Adolescents around the world are frequently using over-the-counter and prescription medications without a doctor's order, a risky practice that can lead to overuse and abuse and is often continued into adulthood, reveals ...

Recommended for you

Fighting opioid addiction in primary care—new study shows it's possible

October 18, 2017
For many of the 2 million Americans addicted to opioids, getting good treatment and getting off prescription painkillers or heroin may seem like a far-off dream.

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.